Clinical brca1/2 reversion analysis identifies hotspot mutations and predicted neoantigens associated with therapy resistance

Stephen J. Pettitt, Jessica R. Frankum, Marco Punta, Stefano Lise, John Alexander, Yi Chen, Timothy A. Yap, Syed Haider, Andrew N.J. Tutt, Christopher J. Lord

Research output: Contribution to journalArticlepeer-review

87 Scopus citations

Fingerprint

Dive into the research topics of 'Clinical brca1/2 reversion analysis identifies hotspot mutations and predicted neoantigens associated with therapy resistance'. Together they form a unique fingerprint.

Medicine & Life Sciences